COVID-19 did originate in Wuhan’s Huanan seafood market: Studies
Understanding the origin of what led to such a scale of devastation is critical in preventing future pandemics
Designing infectious disease warnings that work
Most infectious disease warning systems have been set up to fail as they focus on science, not people.
COVID-19: It’s time to look at the finer details of South Africa’s pandemic picture
The current resurgence driven by the Delta variant finally appears to be subsiding in all nine provinces
Why population immunity is not a realistic goal in Africa’s bid to control COVID-19
The threshold for reaching population immunity depends on many factors. One is the effectiveness of the vaccine. Another is how many people get …
COVID-19: What is the newly launched antibody cocktail therapy
The cocktail therapy claims to reduce hospitalisation and death in COVID-19 patients by 70 per cent
COVID-19: Examining theories for Africa’s low death rates
Africa accounts for 17% of global population, but only 3.5% of the reported global COVID-19 deaths
Understanding zoonotic diseases: Here’s a video primer
While the origins of COVID-19 are still unknown, epidemics like SARS and MERS happened after transfer of pathogens from animals to …
Gaps in South Africa’s relief scheme leave some workers with no income
Exclusion of workers whose employers failed to register them for unemployment insurance remains a major gap
COVID-19: Water a crucial weapon in pandemic fight
Water access, safe sanitation and rapid de-densification of settlements are key interventions in COVID-19 response plan
Countries don’t report disease outbreaks soon enough: WHO chief Ghebreyesus
United Nations health organisation report on IHR implementation tabled in the 73rd World Health Assembly paints a mixed picture
Understanding zoonotic diseases: ‘Humans are changing disease ecosystem’
Burden of neglected zoonotic diseases is vastly under-reported, says Bethan Purse, ecologist, UK Centre for Ecology and Hydrology
How ‘good’ does a COVID-19 vaccine need to be? A new study has answers
A vaccine with an efficacy as low as 60% could still stop the pandemic. However, most, if not all of the population, would have to be vaccinated
Fast COVID-19 vaccine timelines are unrealistic, put integrity of scientists at risk
No vaccine against a coronavirus has successfully navigated the rigours of clinical testing, despite having up to 17 years to do so
Simply Put: The COVID-19 mask
Coronavirus update: Tamil Nadu to lock down Chennai, 3 other districts
ICMR distances itself from study suggesting November peak
Coronavirus update: Spread in new districts since lockdown relaxation
Many districts in eastern states under focus
Coronavirus update: Doubling rate has hastened to 10 days
ICMR starts trial for convalescent plasma as treatment
Coronavirus update: Centre tells Bengal it has highest mortality rate
Citizens can step out, except in containment zones
COVID-19: ‘Thikri pehra’ makes a comeback in Punjab, Haryana
Locals take turns to guard entry and exit points in at least 12,800 Punjab villages
Coronavirus update: Centre identifies 170 hotspots across India
World tally crosses 2 million
Coronavirus update: India tally nears 150
World tally close to 200,000
Coronavirus: Older cousin MERS killed as recent as December
Years of research on SARS, MERS diseases have not helped much in dealing with COVID-19
COVID-19 clues in a community’s sewage: 4 questions answered about watching wastewater for coronavirus
Wastewater monitoring could inform all sorts of public health intervention and disease surveillance programmes
Can nasal vaccines shield against breakthrough infections?
New study argues that nasal vaccines may be necessary to achieve more robust immunity and protection from reinfection by future variants
COVID-19: Next virus could be worse, AstraZeneca vaccine creator Sarah Gilbert says
Research that has not been peer reviewed says that Omicron may be more infectious, but not severe